Anupama Upadhyay, MD
Psychiatry · Dubuque, IANPI 1467407890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.
Across 28 payments — averaging $52.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$340
- Neurocrine Biosciences, Inc.$306
- Otsuka America Pharmaceutical, Inc.$254
- AbbVie$130
- Bioxcel Therapeutics, Inc.$124
- Johnson & Johnson$120
- plus $185 from 4 others
What the payments were for
- Food & beverage$1,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $340 |
| Neurocrine Biosciences, Inc. | 7 | $306 |
| Otsuka America Pharmaceutical, Inc. | 4 | $254 |
| AbbVie(2 entities) | 2 | $130 |
| Bioxcel Therapeutics, Inc. | 1 | $124 |
| Johnson & Johnson | 3 | $120 |
| Alkermes, Inc. | 1 | $93 |
| Lundbeck LLC | 4 | $60 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Indivior Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$242
- INGREZZA$231
- ABILIFY MAINTENA$220
- IGALMI$124
- VRAYLAR$119
How this compares
$1,458 in reported general payments places this provider in the 85th percentile of 245 psychiatry providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 42 | $415 |
| Gabapentin | 13 | $118 |
| Trazodone Hcl | 39 | $104 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Dubuque
- Lee BermanDubuque$3K
- Michael PeroskiDubuque$2K
- Adib KassasDubuque$1K
- Peter SzeibelDubuque$891
- Charles JennischUrbandale$949K
- Manmohan SinghDes Moines$408K
- Jimmy MascaroOttumwa$361K
- Alan WhittersCedar Rapids$170K
- Donald BlackIowa City$19K
- William CoryellIowa City$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.